Authors: Wang, J Chen, P Su, ZF Vallis, K Sandhu, J Cameron, R Hendler, A Reilly, RM

Citation: J. Wang et al., Amplified delivery of indium-111 to EGFR-positive human breast cancer cells, NUCL MED BI, 28(8), 2001, pp. 895-902

Authors: Li, YQ Ballinger, JR Nordal, RA Su, ZF Wong, CS

Citation: Yq. Li et al., Hypoxia in radiation-induced blood-spinal cord barrier breakdown, CANCER RES, 61(8), 2001, pp. 3348-3354

Authors: Su, ZF Ballinger, JR Rauth, AM Abrams, DN Billinghurst, MW

Citation: Zf. Su et al., A novel amine-dioxime chelator for technetium-99m: Synthesis and evaluation of 2-nitroimidazole-containing analogues as markers for hypoxic cells, BIOCONJ CHE, 11(5), 2000, pp. 652-663

Authors: Zhang, XG Su, ZF Ballinger, JR Rauth, AM Pollak, A Thornback, JR

Citation: Xg. Zhang et al., Targeting hypoxia in tumors using 2-nitroimidazoles with peptidic chelators for technetium-99m: Effect of lipophilicity, BIOCONJ CHE, 11(3), 2000, pp. 401-407

Authors: Utsunomiya, K Ballinger, JR Piquette-Miller, M Rauth, AM Tang, W Su, ZF Ichise, M

Citation: K. Utsunomiya et al., Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line, EUR J NUCL, 27(12), 2000, pp. 1786-1792

Authors: Su, ZF Zhang, XG Ballinger, JR Rauth, AM Pollak, A Thornback, JR

Citation: Zf. Su et al., Synthesis and evaluation of two technetium-99m-labeled peptidic e-nitroimidazoles for imaging hypoxia, BIOCONJ CHE, 10(5), 1999, pp. 897-904